Cooper Companies | COO - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Abbott USD 3.6B 330M 2026-06
Align Technology USD 462.67M 2.67M 2026-06
AtriCure USD 82.56M 1.99M 2026-06
Bausch Health Companies USD 901M 88M 2026-06
Baxter International USD 735M 7M 2026-06
Bayer EUR 3.96B 267M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cooper Companies USD 401.3M 274.9M 2026-06
Dentsply International USD 364M 13M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Haemonetics USD 118.94M 1.99M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 3.2B 141M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Novartis USD 3.14B 296M 2026-03
ResMed USD 290.65M 10.86M 2026-06
STAAR Surgical USD 45.14M 6.5M 2026-06
Steris USD 369.7M 17.9M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Utah Medical Products USD 2.56M 48K 2026-03
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06